Cargando…

Hilar cholangiocarcinoma associated with immunoglobulin G4‐positive plasma cells and elevated serum immunoglobulin G4 levels

Immunoglobulin G4 (IgG4)‐related disease is a fibroinflammatory systemic disorder with multiorgan involvement. Proximal bile duct involvement results in IgG4‐related sclerosing cholangitis, which is characterized by a lymphoplasmacytic infiltrate with abundant IgG4‐positive plasma cells and fibrosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Azeem, Nabeel, Ajmera, Veeral, Hameed, Bilal, Mehta, Neil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880190/
https://www.ncbi.nlm.nih.gov/pubmed/29619414
http://dx.doi.org/10.1002/hep4.1164
_version_ 1783311121843748864
author Azeem, Nabeel
Ajmera, Veeral
Hameed, Bilal
Mehta, Neil
author_facet Azeem, Nabeel
Ajmera, Veeral
Hameed, Bilal
Mehta, Neil
author_sort Azeem, Nabeel
collection PubMed
description Immunoglobulin G4 (IgG4)‐related disease is a fibroinflammatory systemic disorder with multiorgan involvement. Proximal bile duct involvement results in IgG4‐related sclerosing cholangitis, which is characterized by a lymphoplasmacytic infiltrate with abundant IgG4‐positive plasma cells and fibrosis. Differentiating between cholangiocarcinoma and IgG4‐sclerosing cholangitis can present a diagnostic dilemma. We describe an unusual presentation of a hepatic mass meeting multiple criteria for IgG4‐sclerosing cholangitis but was ultimately found to be cholangiocarcinoma. Several published case reports describe patients with suspected cholangiocarcinoma who are later found to have IgG4‐sclerosing cholangitis, but few reports have demonstrated the reverse. Distinguishing between cholangiocarcinoma and IgG4‐sclerosing cholangitis is challenging, and a high clinical suspicion for cholangiocarcinoma must always be maintained. (Hepatology Communications 2018;2:349‐353)
format Online
Article
Text
id pubmed-5880190
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-58801902018-04-04 Hilar cholangiocarcinoma associated with immunoglobulin G4‐positive plasma cells and elevated serum immunoglobulin G4 levels Azeem, Nabeel Ajmera, Veeral Hameed, Bilal Mehta, Neil Hepatol Commun Brief Report Immunoglobulin G4 (IgG4)‐related disease is a fibroinflammatory systemic disorder with multiorgan involvement. Proximal bile duct involvement results in IgG4‐related sclerosing cholangitis, which is characterized by a lymphoplasmacytic infiltrate with abundant IgG4‐positive plasma cells and fibrosis. Differentiating between cholangiocarcinoma and IgG4‐sclerosing cholangitis can present a diagnostic dilemma. We describe an unusual presentation of a hepatic mass meeting multiple criteria for IgG4‐sclerosing cholangitis but was ultimately found to be cholangiocarcinoma. Several published case reports describe patients with suspected cholangiocarcinoma who are later found to have IgG4‐sclerosing cholangitis, but few reports have demonstrated the reverse. Distinguishing between cholangiocarcinoma and IgG4‐sclerosing cholangitis is challenging, and a high clinical suspicion for cholangiocarcinoma must always be maintained. (Hepatology Communications 2018;2:349‐353) John Wiley and Sons Inc. 2018-02-28 /pmc/articles/PMC5880190/ /pubmed/29619414 http://dx.doi.org/10.1002/hep4.1164 Text en © 2018 The Authors. Hepatology Communications published by Wiley Periodicals, Inc., on behalf of the American Association for the Study of Liver Diseases. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Brief Report
Azeem, Nabeel
Ajmera, Veeral
Hameed, Bilal
Mehta, Neil
Hilar cholangiocarcinoma associated with immunoglobulin G4‐positive plasma cells and elevated serum immunoglobulin G4 levels
title Hilar cholangiocarcinoma associated with immunoglobulin G4‐positive plasma cells and elevated serum immunoglobulin G4 levels
title_full Hilar cholangiocarcinoma associated with immunoglobulin G4‐positive plasma cells and elevated serum immunoglobulin G4 levels
title_fullStr Hilar cholangiocarcinoma associated with immunoglobulin G4‐positive plasma cells and elevated serum immunoglobulin G4 levels
title_full_unstemmed Hilar cholangiocarcinoma associated with immunoglobulin G4‐positive plasma cells and elevated serum immunoglobulin G4 levels
title_short Hilar cholangiocarcinoma associated with immunoglobulin G4‐positive plasma cells and elevated serum immunoglobulin G4 levels
title_sort hilar cholangiocarcinoma associated with immunoglobulin g4‐positive plasma cells and elevated serum immunoglobulin g4 levels
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880190/
https://www.ncbi.nlm.nih.gov/pubmed/29619414
http://dx.doi.org/10.1002/hep4.1164
work_keys_str_mv AT azeemnabeel hilarcholangiocarcinomaassociatedwithimmunoglobuling4positiveplasmacellsandelevatedserumimmunoglobuling4levels
AT ajmeraveeral hilarcholangiocarcinomaassociatedwithimmunoglobuling4positiveplasmacellsandelevatedserumimmunoglobuling4levels
AT hameedbilal hilarcholangiocarcinomaassociatedwithimmunoglobuling4positiveplasmacellsandelevatedserumimmunoglobuling4levels
AT mehtaneil hilarcholangiocarcinomaassociatedwithimmunoglobuling4positiveplasmacellsandelevatedserumimmunoglobuling4levels